Cardiac hypertrophy associated with impaired regulation of cardiac ryanodine receptor by calmodulin and S100A1

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 305, Issue 1, 2013, Pages

  Yamaguchi, Naohiro ^a,b   Chakraborty, Asima ^a   Huang, Tai Qin ^a   Xu, Le ^a   Gomez, Angela C ^b   Pasek, Daniel A ^a   Meissner, Gerhard ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Calmodulin; Cardiac hypertrophy; Cardiac ryanodine receptor; S100A1

Indexed keywords

AMINO ACID; ATRIAL NATRIURETIC FACTOR; CALCIUM BINDING PROTEIN; CALCIUM CHANNEL; CALCIUM ION; CALMODULIN; MESSENGER RNA; RYANODINE RECEPTOR 2; S100A1; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BINDING SITE; BODY WEIGHT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART FUNCTION; HEART SIZE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE PRESSURE; HEART WEIGHT; MALE; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

CALMODULIN; CARDIAC HYPERTROPHY; CARDIAC RYANODINE RECEPTOR; S100A1;

ACTION POTENTIALS; ANIMALS; ATRIAL NATRIURETIC FACTOR; BINDING SITES; CALCIUM; CALCIUM SIGNALING; CALMODULIN; CARDIOMEGALY; HEART FAILURE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUTATION, MISSENSE; MYOCARDIAL CONTRACTION; RNA, MESSENGER; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; S100 PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84879561616     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00144.2013     Document Type: Article

References (37)

1. Anderson ME, Brown JH, Bers DM. CaMKII in myocardial hypertrophy and heart failure. J Mol Cell Cardiol 51: 468-473, 2011.
2. Balshaw DM, Xu L, Yamaguchi N, Pasek DA, Meissner G. Calmodulin binding and inhibition of cardiac muscle calcium release channel (ryanodine receptor). J Biol Chem 276: 20144-20153, 2001.
3. Barrick CJ, Rojas M, Schoonhoven R, Smyth SS, Threadgill DW. Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal-and background-dependent development of concentric left ventricular hypertrophy. Am J Physiol Heart Circ Physiol 292: H2119-H2130, 2007.
4. Brinks H, Rohde D, Voelkers M, Qiu G, Pleger ST, Herzog N, Rabinowitz J, Ruhparwar A, Silvestry S, Lerchenmuller C, Mather PJ, Eckhart AD, Katus HA, Carrel T, Koch WJ, Most P. S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes. J Am Coll Cardiol 58: 966-973, 2011.
5. Bunting M, Bernstein KE, Greer JM, Capecchi MR, Thomas KR. Targeting genes for self-excision in the germ line. Genes Dev 15: 1524-1528, 1999.
6. Capes EM, Loaiza R, Valdivia HH. Ryanodine receptors. Skelet Muscle 1: 18, 2011.
7. Du XJ, Cole TJ, Tenis N, Gao XM, Kontgen F, Kemp BE, Heierhorst J. Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice. Mol Cell Biol 22: 2821-2829, 2002.
8. 2+ sensitivity of skeletal and cardiac muscle ryanodine receptors in the presence of calmodulin. Am J Physiol Cell Physiol 279: C724-C733, 2000.
9. Gangopadhyay JP, Ikemoto N. Aberrant interaction of calmodulin with the ryanodine receptor develops hypertrophy in the neonatal cardiomyocyte. Biochem J 438: 379-387, 2011.
10. 2+ signaling in mouse cardiomyocytes with ablated S100A1 protein. Gen Physiol Biophys 28: 371-383, 2009.
11. Hamilton SL, Serysheva II. Ryanodine receptor structure: progress and challenges. J Biol Chem 284: 4047-4051, 2009.
12. Hino A, Yano M, Kato T, Fukuda M, Suetomi T, Ono M, Murakami W, Susa T, Okuda S, Doi M, Kobayashi S, Yamamoto T, Koseki N, Kyushiki H, Ikemoto N, Matsuzaki M. Enhanced binding of calmodulin to the ryanodine receptor corrects contractile dysfunction in failing hearts. Cardiovasc Res 96: 433-443, 2012.
13. Kato K, Kimura S, Haimoto H, Suzuki F. S100a0 (alpha alpha) protein: distribution in muscle tissues of various animals and purification from human pectoral muscle. J Neurochem 46: 1555-1560, 1986.
14. Kettlewell S, Most P, Currie S, Koch WJ, Smith GL. S100A1 increases the gain of excitation-contraction coupling in isolated rabbit ventricular cardiomyocytes. J Mol Cell Cardiol 39: 900-910, 2005.
15. Kim HS, Lee G, John SW, Maeda N, Smithies O. Molecular phenotyping for analyzing subtle genetic effects in mice: application to an angiotensinogen gene titration. Proc Natl Acad Sci USA 99: 4602-4607, 2002.
16. Kishimoto I, Tokudome T, Horio T, Garbers DL, Nakao K, Kangawa K. Natriuretic peptide signaling via guanylyl cyclase (GC)-A: an endogenous protective mechanism of the heart. Curr Cardiol Rev 5: 45-51, 2009.
17. Meissner G. Molecular regulation of cardiac ryanodine receptor ion channel. Cell Calcium 35: 621-628, 2004.
18. Meissner G. Regulation of ryanodine receptor ion channels through posttranslational modifications. Curr Top Membr 66: 91-113, 2010.
19. 2+, adenine nucleotide, and calmodulin. J Biol Chem 262: 3065-3073, 1987.
20. Most P, Pleger ST, Völkers M, Heidt B, Boerries M, Weichenhan D, Löffler E, Janssen PM, Eckhart AD, Martini J, Williams ML, Katus HA, Remppis A, Koch WJ. Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. J Clin Invest 114: 1550-1563, 2004.
21. 2+ binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance. J Biol Chem 278: 33809-33817, 2003.
22. Nitu FR, Fruen BR, Rohde D, Most P, Bers DM, Thomas DD, Cornea RL. FRET detection of CaM-RyR2 binding modulation by S100A1. Biophys J 104: 446a, 2013.
23. Pleger ST, Shan C, Ksienzyk J, Bekeredjian R, Boekstegers P, Hinkel R, Schinkel S, Leuchs B, Ludwig J, Qiu G, Weber C, Raake P, Koch WJ, Katus HA, Muller OJ, Most P. Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model. Sci Transl Med 3: 92ra64, 2011.
24. Prosser BL, Hernandez-Ochoa EO, Schneider MF. S100A1 and calmodulin regulation of ryanodine receptor in striated muscle. Cell Calcium 50: 323-331, 2011.
25. Prosser BL, Wright NT, Hernandez-Ochoa EO, Varney KM, Liu Y, Olojo RO, Zimmer DB, Weber DJ, Schneider MF. S100A1 binds to the calmodulin-binding site of ryanodine receptor and modulates skeletal muscle excitation-contraction coupling. J Biol Chem 283: 5046-5057, 2008.
26. Sutko JL, Airey JA, Welch W, Ruest L. The pharmacology of ryanodine and related compounds. Pharmacol Rev 49: 53-98, 1997.
27. 2+ release channel (ryanodine receptor) of skeletal muscle. Biochemistry 36: 11496-11503, 1997.
28. Volkers M, Loughrey CM, Macquaide N, Remppis A, DeGeorge BR Jr, Wegner FV, Friedrich O, Fink RH, Koch WJ, Smith GL, Most P. S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes. Cell Calcium 41: 135-143, 2007.
29. 2+ handling, sarcomeric, and mitochondrial function. J Biomed Biotech 2010: 1-10, 2010.
30. Wehrens XH, Lehnart SE, Marks AR. Intracellular calcium release and cardiac disease. Annu Rev Physiol 67: 69-98, 2005.
31. 2+ release channel (ryanodine receptor). Biophys J 86: 797-804, 2004.
32. 2+ release channels (ryanodine receptors) by multiple mechanisms. J Biol Chem 274: 32680-32691, 1999.
33. Yamaguchi N, Chakraborty A, Pasek DA, Molkentin JD, Meissner G. Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling molecules. Am J Physiol Heart Circ Physiol 300: H2187-H2195, 2011.
34. 2+ release in skeletal muscle expressing ryanodine receptor impaired in regulation by calmodulin and S100A1. Am J Physiol Cell Physiol 300: C998-C1012, 2011.
35. 2+ release channel. J Clin Invest 117: 1344-1353, 2007.
36. 2+ release channel (ryanodine receptor). J Biol Chem 278: 23480-23486, 2003.
37. Yano M, Yamamoto T, Ikeda Y, Matsuzaki M. Mechanisms of disease: ryanodine receptor defects in heart failure and fatal arrhythmia. Nat Clin Pract Cardiovasc Med 3: 43-52, 2006.